An Injectable Liposome–Hydrogel Composite for Targeted Delivery of a Non‐Lactylated Peptide to Rebalance Bone Metabolism in Hyperlipidemia
Advanced Healthcare Materials · 2026-05 · 15 (17)
DOI: 10.1002/adhm.202505684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 21.02.2026. Verfasst von Tiantian Zhu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prosthodontics, Cheeloo College of Medicine, School and Hospital of Stomatology, Shandong University, Shandong Key Laboratory of Oral T…. Hauptthemen laut MEDLINE: Liposomes, Hyperlipidemias, Peptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Key Technology Research and Development Program of Shandong Province, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
The pathological bone microenvironment in hyperlipidemia severely impedes regeneration, which is a challenge that is poorly addressed by current therapies. Although we previously identified the pro‐osteogenic role of non‐lactylated endosomal trafficking factor 1 (ENTR1), its instability limited therapeutic application. Therefore, we designed DR8 (DENSRLRR), a stable non‐lactylated peptide that mimics the functional core of non‐lactylated ENTR1, to restore bone homeostasis under high‐fat conditions. For effective peptide delivery, we engineered an injectable, reactive oxygen species (ROS)‐responsive platform, HPA/DR8@LPs‐E7 (HLP2). In this system, DR8 was loaded into bone‐targeting E7 (EPLQLKM) peptide‐modified liposomes, which were then encapsulated within a ROS‐responsive phenylboronic ester‐crosslinked hyaluronic acid‐poly(vinyl alcohol) hydrogel. This design facilitated on‐demand release within the oxidative bone niche. HLP2 effectively scavenged excess ROS, enhanced cell recruitment, promoted angiogenesis, and potently stimulated osteogenesis. Mechanistically, it modulated paracrine signaling of bone marrow mesenchymal stem cells to restore the receptor activator of nuclear factor κB ligand/osteoprotegerin balance, thereby suppressing NF‐κB signal pathway‐mediated osteoclastogenesis. In hyperlipidemic rats with calvarial defects, HLP2 significantly accelerated bone regeneration. This study has established a paradigm‐shifting strategy that synergizes a multifunctional metabolic peptide with an adaptive biomaterial platform for the treatment of metabolic bone disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Prosthodontics, Cheeloo College of Medicine, School and Hospital of Stomatology, Shandong University, Shandong Key Laboratory of Oral Tissue Regeneration, Shandong Engineering Laboratory for Dental Materia…
- Department of Prosthodontics, Linyi People's Hospital, Shandong Second Medical University, Linyi, Shandong, China.
- Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Researchcollege of Stomatology, Xi'an Jiaotong University, Xi'an, China.
ORCID-Profile: Tiantian Zhu, Jing Lan
Förderung
- Key Technology Research and Development Program of Shandong Province
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Zhu, T., Ren, H., Ma, A., Zhai, C., Shang, J., Zhang, T., Zhu, D., Wang, W., Yang, Z., Zhao, F., Li, C., & Lan, J. (2026). An Injectable Liposome–Hydrogel Composite for Targeted Delivery of a Non‐Lactylated Peptide to Rebalance Bone Metabolism in Hyperlipidemia. Advanced Healthcare Materials, 15(17). https://doi.org/10.1002/adhm.202505684
Vancouver
Zhu T, Ren H, Ma A, Zhai C, Shang J, Zhang T, et al. An Injectable Liposome–Hydrogel Composite for Targeted Delivery of a Non‐Lactylated Peptide to Rebalance Bone Metabolism in Hyperlipidemia. Advanced Healthcare Materials. 2026;15(17). doi:10.1002/adhm.202505684
BibTeX
@article{Zhu2026,
author = {Zhu, Tiantian and Ren, Huiping and Ma, Anquan and Zhai, Chuanyao and Shang, Jiaming and Zhang, Ting and Zhu, Danmin and Wang, Wenhao and Yang, Ziqing and Zhao, Feifei and Li, Chuanhua and Lan, Jing},
title = {An Injectable Liposome–Hydrogel Composite for Targeted Delivery of a Non‐Lactylated Peptide to Rebalance Bone Metabolism in Hyperlipidemia},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {17},
doi = {10.1002/adhm.202505684}
}
EUVIMED